Immobilization quality and cardiopulmonary effects of etorphine alone compared with etorphine-azaperone in blesbok (Damaliscus pygargus phillipsi).


Journal

Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 16 04 2019
revised: 04 09 2019
accepted: 07 10 2019
pubmed: 9 6 2020
medline: 10 4 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

To evaluate the immobilization quality and cardiopulmonary effects of etorphine alone compared with etorphine-azaperone in blesbok (Damaliscus pygargus phillipsi). Blinded, randomized, crossover design. A total of 12 boma-habituated female blesbok weighing [mean ± standard deviation (SD)] 57.5 ± 2.5 kg. Each animal was administered etorphine (0.09 mg kg No difference was observed in time to first sign, immobilization time and recovery times between treatments. Time to head up was longer with etorphine-azaperone (0.5 ± 0.2 versus 0.4 ± 0.2 minutes; p = 0.015). Etorphine caused higher arterial blood pressures (mean: 131 ± 17 versus 110 ± 11 mmHg, p < 0.0001), pH, rectal temperature and arterial oxygen partial pressure (59.2 ± 7.7 versus 42.2 ± 9.8 mmHg), but lower heart (p = 0.002) and respiratory rates (p = 0.01). Etorphine-azaperone combination led to greater impairment of ventilatory function, with higher end-tidal carbon dioxide (p < 0.0001) and arterial partial pressure of carbon dioxide (58.0 ± 4.5 versus 48.1 ± 5.1 mmHg). Immobilization quality was greater with etorphine-azaperone than with etorphine alone (median scores: 4 versus 3; p < 0.0001). Both treatments provided satisfactory immobilization of blesbok; however, in addition to a deeper level of immobilization, etorphine-azaperone caused greater ventilatory impairment. Oxygen supplementation is recommended with both treatments.

Identifiants

pubmed: 32507718
pii: S1467-2987(20)30051-9
doi: 10.1016/j.vaa.2019.10.012
pii:
doi:

Substances chimiques

Hypnotics and Sedatives 0
Narcotic Antagonists 0
Azaperone 19BV78AK7W
Etorphine 42M2Y6NU9O
Naltrexone 5S6W795CQM
Oxygen S88TT14065

Types de publication

Journal Article Randomized Controlled Trial, Veterinary

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-536

Informations de copyright

Copyright © 2020 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.

Auteurs

Eugenio Gaudio (E)

Department of Animal Medicine Production and Health, University of Padova, Padova, Italy; Department of Animal Sciences, Stellenbosch University, Stellenbosch, South Africa. Electronic address: eugenio.gaudio@phd.unipd.it.

Liesel L Laubscher (LL)

Department of Animal Sciences, Stellenbosch University, Stellenbosch, South Africa; Wildlife Pharmaceuticals (Pty) Ltd., White River, South Africa.

Silke Pfitzer (S)

School of Veterinary and Life Sciences, Murdoch University, Perth, Australia.

Jacobus P Raath (JP)

Wildlife Pharmaceuticals (Pty) Ltd., White River, South Africa; Wildlifevets.com, Ngongoni Game Lodge, Karino, South Africa.

Louw C Hoffman (LC)

Department of Animal Sciences, Stellenbosch University, Stellenbosch, South Africa; Centre for Nutrition and Food Sciences, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, Australia.

Giulia M De Benedictis (GM)

Department of Animal Medicine Production and Health, University of Padova, Padova, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH